Researchers at Ulm University Hospital discovered that mutations in the brain’s MC4R gene, which cause obesity, also lower ...

The U.S. Food and Drug Administration (FDA) has approved Revuforj (revumenib), which is a menin inhibitor, for the treatment ...

If you have experience with R or want a quick way to generate a regression with statsmodels using a pandas DataFrame, you can ...

Biodesix expands its Bio-Rad partnership to validate ddPCR cancer assays, starting with ESR1 mutation testing in breast ...

For decades, Paranthropus robustus has intrigued scientists as a powerful, big-jawed cousin of early humans. Now, thanks to ancient protein analysis, researchers have cracked open new secrets hidden ...

Cystic fibrosis (CF) therapeutics refer to treatments designed to manage and alleviate the symptoms of cystic fibrosis, a ...

I 'm a big fan of Python for data analysis, but even I get curious about what else is available. R has long been the go-to ...

AI-advanced drug candidate achieves complete metabolic response after two cycles in patient who failed CAR-T and bispecific ...

Get Apollo Global's Q3 earnings preview, segment outlook, and fair value insights. See if now is the right time to invest.

The early-stage pipeline for amyotrophic lateral sclerosis drugs exploded last year. After ALS R&D notched 28 new trial starts in 2023, the rate more than doubled to 60 in 2024, Citeline recently ...

Intellia Therapeutics, Inc. is rated Hold due to uncertainty from dosing pause in its MAGNITUDE program for ATTR. Learn more ...

"ESMO 2025: J&J eyes Rybrevant indication expansion to HNSCC on Phase II victory" was originally created and published by ...